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Detection of Chlamydiaceae and 
Chlamydia-like organisms on the 
ocular surface of children and adults 
from a trachoma-endemic region
Ehsan Ghasemian 1, Aleksandra Inic-Kanada 1, Astrid Collingro  2, Florian Tagini3, 
Elisabeth Stein1, Hadeel Alchalabi1, Nadine Schuerer1, Darja Keše4, Balgesa Elkheir Babiker5, 
Nicole Borel6, Gilbert Greub  3,7 & Talin Barisani-Asenbauer1
Trachoma, the leading infectious cause of blindness, is caused by Chlamydia trachomatis (Ct), a 
bacterium of the phylum Chlamydiae. Recent investigations revealed the existence of additional 
families within the phylum Chlamydiae, also termed Chlamydia-like organisms (CLOs). In this study, 
the frequency of Ct and CLOs was examined in the eyes of healthy Sudanese (control) participants and 
those with trachoma (case). We tested 96 children (54 cases and 42 controls) and 93 adults (51 cases and 
42 controls) using broad-range Chlamydiae and Ct-specific (omcB) real-time PCR. Samples positive by 
broad-range Chlamydiae testing were subjected to DNA sequencing. Overall Chlamydiae prevalence 
was 36%. Sequences corresponded to unclassified and classified Chlamydiae. Ct infection rate was 
significantly higher in children (31.5%) compared to adults (0%) with trachoma (p < 0.0001). In general, 
21.5% of adults and 4.2% of children tested positive for CLOs (p = 0.0003). Our findings are consistent 
with previous investigations describing the central role of Ct in trachoma among children. This is the 
first study examining human eyes for the presence of CLOs. We found an age-dependent distribution 
of CLO DNA in human eyes with significantly higher positivity in adults. Further studies are needed to 
understand the impact of CLOs in trachoma pathogenicity and/or protection.
Trachoma constitutes the leading infectious cause of blindness worldwide1. It is considered a public health prob-
lem in 41 countries and is responsible for the visual impairment of approximately 1.9 million people, of whom 
0.450 million are blind2. Trachoma is caused by repeated infection of the conjunctiva with Chlamydia trachomatis, 
a bacterium of the phylum Chlamydiae1,3. The majority of infections heal without sequelae, whereas subgroups of 
infected patients develop chronic inflammation and scarring of the ocular surface. However, the factors respon-
sible for the different outcomes are not yet fully understood.
The phylum Chlamydiae was originally considered to consist of only a single family, the Chlamydiaceae4. 
Since the mid-1990s, advances in molecular techniques have uncovered new Chlamydiae, termed Chlamydia-like 
organisms (CLOs) or environmental Chlamydiae, belonging to novel families in this phylum; i.e., the 
Parachlamydiaceae, Simkaniaceae, Rhabdochlamydiaceae, Waddliaceae, Candidatus Piscichlamydiaceae, Candidatus 
Parilichlamydiaceae, Candidatus Amphibiichlamydiaceae, Candidatus Clavichlamydiaceae, and Criblamydiaceae5–9. 
There is also molecular evidence for an even greater diversity within the phylum, suggesting the existence of more 
than 180 families therein10. Chlamydiae are obligate intracellular bacteria with a biphasic developmental cycle 
that includes an extra-cellular elementary body and an intracellular dividing reticulate body11–13. CLOs have been 
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identified from various environmental sources and hosts such as humans, warm-blooded terrestrial vertebrates, fish, 
reptiles, amphibians, arthropods, and eukaryotic microorganisms such as amoebae6–9,14,15. Parachlamydia acantham-
oebae and Neochlamydia hartmannellae were found in eyes of cats with keratitis, conjunctivitis, and other ocular 
diseases16,17. In a study on the eyes of sheep with conjunctivitis, DNA of uncultured CLOs was found in two-thirds 
(26/32) of the samples18. The presence of P. acanthamoebae and other CLOs have also been reported in symptomatic 
eyes of guinea pigs and in the one-day disposal contact lenses of their owner19. Additionally, results from several 
studies on humans and animals have shown the presence of CLOs in urogenital sites, the skin, respiratory tract and 
eye20–22. Furthermore, to date, Parachlamydiaceae species (spp.), Simkania negevensis and Waddlia chondrophila have 
been linked to human respiratory diseases and adverse pregnancy outcomes with various levels of evidence5,23–27.
Increasing evidence suggests an association between the presence of non-C. trachomatis bacteria and tra-
choma. Dean et al. reported a high prevalence of Chlamydia psittaci, Chlamydia suis, Chlamydia pecorum, and 
Chlamydia pneumoniae in eyes of patients with trachoma from Nepal28,29. Results from two separate studies 
in Tanzania, one, a cross-sectional study on children30 and the other a case-control study on adults31, revealed 
a strong association between non-chlamydial bacterial infections (such as Streptococcus pneumoniae and 
Haemophilus influenza) and clinical signs of trachoma in children and adults. These findings were independently 
supported by two studies on Gambian children and adults with signs of trachoma32,33. In addition, a study in 
Ethiopia suggested that conjunctival colonization with pathogenic bacterial species is more likely in patients with 
trachomatous trichiasis34. Trichiasis, the introversion of the eyelashes, has been described repeatedly as a direct 
route for conjunctival colonization with pathogens in the eyes of patients with trachoma34,35.
Altogether, such surveys provide insights into the possible role of various chlamydial species on ocular sur-
face pathogenicity. Several similarities have been demonstrated between different CLOs and the Chlamydiaceae 
concerning their developmental cycle, virulence factors, and invasion mechanisms to the host cells5,10,20,36,37. 
Considering the importance of C. trachomatis in trachoma and the status of CLOs as highly prevalent microor-
ganisms in the environment, it is necessary to examine the frequency of CLOs on the ocular surface and their 
possible association with trachoma. The main aim of this case-control study was therefore to investigate the fre-
quency of C. trachomatis and other Chlamydiae in ocular samples of children and adults from Al Qadarif region 
in Sudan (Fig. 1) with trachoma and healthy participants.
Results
Study population. The distribution of participants by age, sex, and grade of trachoma is shown in Table 1. The 
study population comprised 189 individuals, of whom 96 (children) were aged 1–9 years and 93 (adults) aged 15–88 
years. The median ages of the children and adults were 5 and 56.3 years, respectively.
Broad-range Chlamydiae real-time polymerase chain reaction and sequence classification. Among 
189 swab samples in total, 68 (36%) were positive for Chlamydiae DNA. All the nucleic acid extraction negative controls 
and real-time polymerase chain reaction (PCR) negative controls remained negative when tested with Chlamydiae 
real-time PCR. Although no swab has been taken as a field control, the risk of contamination can be ruled out because 
of existing differences in the distribution of positive samples for Chlamydiae real-time PCR and various profiles of 
sequences corresponding to different Chlamydiae families among children and adults as well as cases and controls. 
There were no statistically significant differences in positivity for Chlamydiae or C. trachomatis between male and female 
Figure 1. Location of sampling sites:  Al Qadarif region, Sudan. The Map marks the city of Al Qadarif, which 
is the capital of the state Al Qadarif in central Sudan (the map is generated in Microsoft PowerPoint 2016 
Software).
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participants (p > 0.05). The average threshold cycle (CT) value for Chlamydiae real-time PCR was 34 ± 9.4. A standard 
curve was prepared to evaluate the efficiency of real-time PCR and to achieve a comparative concentration (inclusion 
forming units (IFUs)) for the samples based on their CT values (Supplementary Fig. S1). Among the 68 positive sam-
ples, 55 (81%) yielded assembled forward and reverse sequences (~200 bp) that were used for BLAST-n analysis, Naïve 
Bayesian classification in RDP, and phylogenetic analysis (Table 2, Figs 2 and 3) (Supplementary Tables S1 and S2). 
We were not able to assemble the sequences of the 13 remaining samples owing to multiple peaks in chromatogram 
lanes, which either might suggest the presence of more than one member of Chlamydiae in the ocular swab, or low 
amounts of DNA in the sample, which can cause PCR-generated artefactual species variation38–41.
BLAST-n results for sequences were categorized based on the first (Table 2) and second BLAST-hit identifi-
cation (excluding uncultured bacteria) (Supplementary Table S2) and closest 16 S ribosomal RNA (16S rRNA) 
classification match (Table 2). Of 16 samples that were detected as Chlamydiales bacterium by first BLAST-hit 
identification, nine sequences had highest similarity to Chlamydiales bacterium CRIB 32 and CRIB 33, six to 
Chlamydiales bacterium NS11, and one to both Chlamydiales bacterium CRIB 32/NS11 (Table 2). Sequences for 
Chlamydiales bacterium CRIB 32/33 and Chlamydiales bacterium NS11 were previously identified in domestic 
water and human nasal samples, respectively42,43.
Based on this 16S rRNA classification, four sequences corresponded to new species levels, 21 to new genus 
levels, and one to a new family level of the phylum Chlamydiae. Altogether, 54 out of 55 assembled sequences were 
identified as the nearest neighbor to four families including Chlamydiaceae (55.6%), Parachlamydiaceae (29.6%), 
Simkaniaceae (13%), and Criblamydiaceae (1.9%) (Table 2). Additionally, the retrieved 16S rRNA gene sequences 
were classified using the Naïve Bayesian Classifier of RDP, by which the majority of the sequences were also 
placed within Chlamydiaceae (52.7%) and Parachlamydiaceae (27.3%). Owing to length, the remaining sequences 
could only be assigned as unclassified Chlamydiales (20%) (Table 2). In general, the prevalence of Chlamydiaceae 
sequences was significantly higher in children than in adults (p = 0.0069) and CLO sequences were more frequent 
in adults than in children (p = 0.0003) (Figs 4 and 5).
Phylogenetic analysis of sequences. Phylogenetic analyses were performed with two different data-
sets to obtain better insights into the taxonomic placement of the 16S rRNA sequences from this study. The 
sequences obtained in this study were added to a Bayesian inference tree of full-length chlamydial 16S rRNA 
gene sequences representing the major known chlamydial lineages using Parsimony (Fig. 2) (Supplementary 
Table S1 and Supplementary Fig. S2). Similar to BLAST-n results, the majority of sequences were assigned to the 
Chlamydiaceae (52.7%). The sequences affiliating with CLOs grouped together with sequences of members of the 
Parachlamydiaceae (9.1%) and Criblamydiaceae (1.8%). A total of 36.3% of the sequences were closely related to 
as yet unclassified chlamydial sequences and reflect the high diversity within the Chlamydiae. A maximum likeli-
hood phylogenetic tree (Fig. 3) revealed the phylogenetic relationship of the obtained 16S rRNA gene sequences 
to their closest BLAST-hit including these sequences along with some reference sequences.
Prevalence of Chlamydiae DNA in children. Of 96 samples from children (54 in the trachomatous 
inflammation-follicular (cTF) group and 42 in the control (cC) group), 32 (33.3%) yielded positive results for 
Chlamydiae (25 in the cTF group and 7 in the cC group). The prevalence of Chlamydiae DNA in the cTF group 
(45.3%) was significantly higher than that in the cC group (16.7%) (p = 0.0032). The average CT values in the cTF 
and cC groups tested using Chlamydiae real-time PCR were 30.8 ± 9.2 and 35.7 ± 0.7, respectively (p = 0.0154) 
(Fig. 6a).
Children case 
(N = 54)
Children control 
(N = 42)
Adults case 
(N = 51)
Adults control 
(N = 42)
n % n % n % n %
Sex
Male 31 57.4 22 52.4 17 33.3 12 28.6
Female 23 42.6 20 47.6 34 66.7 30 71.4
Age
9≤ 54 100 42 100 — — — —
15–25 — — — — 2 3.9 2 4.8
26–35 — — — — 4 7.8 4 9.5
36–45 — — — — 8 15.7 8 19
46–55 — — — — 7 13.7 8 19
56–65 — — — — 11 21.6 4 9.5
>65 — — — — 19 37.2 16 38.1
Trachoma grade
TF 54 100 0 0 — — 0 0
TI — — 0 0 — — 0 0
TS — — 0 0 — — 0 0
TT — — 0 0 51 100 0 0
Table 1. Baseline and clinical characteristics of study participants in Al Qadarif-Sudan.
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Household ID % Best BLAST hit* (Accession number)
% Closest BLAST match for 
16S rRNA gene
Naïve Bayesian classification 
(RDP, 70% confidence interval)
Accession 
number#
Children Case
cTF-006 100% Chlamydia trachomatis (CP020537.1) 100% Chlamydia trachomatis Chlamydia
cTF-008 100% Chlamydia trachomatis (CP020537.1) 100% Chlamydia trachomatis Chlamydia
cTF-012 99% Chlamydia trachomatis (CP020537.1) 99% Chlamydia trachomatis Chlamydia  MH119791
cTF-013 99% Chlamydia trachomatis (CP020537.1) 99% Chlamydia trachomatis Chlamydia  MH119792
cTF-017 99% Chlamydia trachomatis (CP020537.1) 99% Chlamydia trachomatis Chlamydia  MH119793
cTF-018 95% Neochlamydia SP. (LC122507.1) 94% Parachlamydiaceae Neochlamydia  MH119794
cTF-020 100% Chlamydia trachomatis (CP020537.1) 100% Chlamydia trachomatis Chlamydia
cTF-021 100% Chlamydia trachomatis (CP020537.1) 100% Chlamydia trachomatis Chlamydia
cTF-025 95% Chlamydiales bacterium CRIB 32 (EU363464.1) 94% Parachlamydiaceae Unclassified Parachlamydiaceae  MH119795
cTF-029 100% Chlamydia trachomatis (CP020537.1) 100% Chlamydia trachomatis Chlamydia
cTF-031 100% Chlamydia trachomatis (CP020537.1) 100% Chlamydia trachomatis Chlamydia
cTF-037 100% Chlamydia trachomatis (CP020537.1) 100% Chlamydia trachomatis Chlamydia
cTF-038 100% Chlamydia trachomatis (CP020537.1) 100% Chlamydia trachomatis Chlamydia
cTF-044 100% Chlamydia trachomatis (CP020537.1) 100% Chlamydia trachomatis Chlamydia
cTF-048 100% Chlamydia trachomatis (CP020537.1) 100% Chlamydia trachomatis Chlamydia
cTF-051 95% Criblamydia sequanensis (NR_115696.1) 95% Criblamydia Parachlamydia  MH119796
cTF-057 100% Chlamydia trachomatis (CP020537.1) 100% Chlamydia trachomatis Chlamydia
cTF-059 100% Chlamydia trachomatis (CP020537.1) 99% Chlamydia trachomatis Chlamydia
cTF-060 99% Chlamydia caviae (NR_074946.1)/felis (JN606073.1) 99% Chlamydia caviae/ felis Chlamydia  MH119797
cTF-068 100% Chlamydia trachomatis (CP020537.1) 100% Chlamydia trachomatis Chlamydia
cTF-069 99% Chlamydia gallinacea (KX603685.1) 99% Chlamydia gallinacea Chlamydia  MH119798
cTF-074 97% Parachlamydia acanthamoebae (JN051144.1) 96% Parachlamydia Parachlamydia  MH119799
cTF-088 100% Chlamydia trachomatis (CP020537.1) 100% Chlamydia trachomatis Chlamydia
cTF-092§ 92% Chlamydiales bacterium CRIB33 (EU683887.1) 86% Chlamydiales Unclassified Parachlamydiaceae
cTF-100 Chlamydiales (Failed assembly) Chlamydiales (Failed assembly) Chlamydiales (Failed assembly)
Children Control
cC-005 Chlamydiales (Failed assembly) Chlamydiales (Failed assembly) Chlamydiales (Failed assembly)
cC-015 99% Chlamydia caviae (NR_074946.1)/felis (JN606073.1) 99% Chlamydia caviae/ felis Chlamydia  MH119789
cC-033 Chlamydiales (Failed assembly) Chlamydiales (Failed assembly) Chlamydiales (Failed assembly)
cC-042 100% Chlamydia caviae (NR_074946.1)/felis (AP006861.1) 100% Chlamydia caviae/ felis Chlamydia
cC-056 Chlamydiales (Failed assembly) Chlamydiales (Failed assembly) Chlamydiales (Failed assembly)
cC-096 Chlamydiales (Failed assembly) Chlamydiales (Failed assembly) Chlamydiales (Failed assembly)
cC-099 98% Chlamydia sp. 2742–308 (CP014639.1) 97% Chlamydia caviae Unclassified Chlamydiaceae  MH119790
Adults Case
aTT-200 95% Chlamydiales bacterium NS11 (JN606074.1) 93% Parachlamydiaceae Neochlamydia  MH119778
aTT-201 95% Chlamydiales bacterium NS11 (JN606074.1) 93% Chlamydiaceae Unclassified Chlamydiales  MH119779
aTT-203 100% Chlamydia caviae (NR_074946.1)/felis (JN606073.1) 100% Chlamydia caviae/ felis Chlamydia
aTT-207 92% Neochlamydia hartmannellae (NR_025037.1) 92% Parachlamydiaceae Neochlamydia  MH119780
aTT-209 100% Chlamydia caviae (NR_074946.1)/felis (AP006861.1) 100% Chlamydia caviae/ felis Chlamydia
aTT-211 98% Chlamydiales bacterium CRIB 32 (EU363464.1) 90% Simkaniaceae Unclassified Chlamydiales  MH119781
aTT-214 97% Chlamydia sp. (CP014639.1)/ Chlamydia pecorum (CP004033.1) 97% Chlamydia pecorum Chlamydophila  MH119782
Continued
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Among the 32 positive samples, 27 sequences were assembled. Sequences from 26 samples corresponded to 
various families: 22 (84.6%) were positive for Chlamydiaceae, three (11.5%) for Parachlamydiaceae, and one for 
(3.8%) Criblamydiaceae (Table 2 and Fig. 4a). In addition, one sample (cTF092) exhibited 87% similarity to the 
order Chlamydiales and appeared to be phylogenetically close to unclassified Chlamydiales (Table 2 and Fig. 2).
In the cTF group, among the 19 sequences classified as Chlamydiaceae, 17 (89.5%) showed 99–100% homology 
to C. trachomatis (p < 0.0001). These results were confirmed using omcB real-time PCR. In general, C. trachomatis 
Household ID % Best BLAST hit* (Accession number)
% Closest BLAST match for 
16S rRNA gene
Naïve Bayesian classification 
(RDP, 70% confidence interval)
Accession 
number#
aTT-216 97% Chlamydiales bacterium CRIB 32 (EU363464.1) 92% Parachlamydiaceae Neochlamydia  MH119783
aTT-217 98% Chlamydiales bacterium NS11 (JN606074.1) 92% Parachlamydiaceae Unclassified Parachlamydiaceae  MH119784
aTT-219 Chlamydiales (Failed assembly) Chlamydiales (Failed assembly) Chlamydiales (Failed assembly)
aTT-225 95% Chlamydiales bacterium NS11 (JN606074.1) 92% Simkaniaceae Unclassified Chlamydiales  MH119785
aTT-226 95% Chlamydiales bacterium CRIB 32 (EU363464.1)/ NS11 (JN606074.1) 90% Parachlamydiaceae Unclassified Chlamydiales  MH119786
aTT-228 96% Chlamydiales bacterium NS11 (JN606074.1) 91% Simkaniaceae Unclassified Chlamydiales  MH119787
aTT-236 Chlamydiales (Failed assembly) Chlamydiales (Failed assembly) Chlamydiales (Failed assembly)
aTT-237 99% Chlamydia caviae (NR_074946.1)/ felis (AP006861.1) 99% Chlamydia caviae/ felis Unclassified Chlamydiaceae  MH119788
aTT-298 Chlamydiales (Failed assembly) Chlamydiales (Failed assembly) Chlamydiales (Failed assembly)
Adults Control
aC-250 97% Chlamydiales bacterium CRIB 32 (EU363464.1) 90% Simkaniaceae Unclassified Chlamydiales  MH119764
aC-252 Chlamydiales (Failed assembly) Chlamydiales (Failed assembly) Chlamydiales (Failed assembly)
aC-253 98% Parachlamydia acanthamoebae (NR_026357.1)
98% Parachlamydia 
acanthamoebae Parachlamydia  MH119765
aC-257 94% Simkania negevensis (NR_074932.1) 94% Simkaniaceae Unclassified Chlamydiales  MH119766
aC-258 Chlamydiales (Failed assembly) Chlamydiales (Failed assembly) Chlamydiales (Failed assembly)
aC-259 96% Chlamydia trachomatis (CP019387.1) 96% Chlamydia Unclassified Chlamydiaceae  MH119767
aC-260 97% Chlamydiales bacterium CRIB 32 (EU363464.1) 90% Parachlamydiaceae Unclassified Parachlamydiaceae  MH119768
aC-261 98% Chlamydia caviae (NR_074946.1)/felis (JN606073.1) 98% Chlamydia caviae/ felis Unclassified Chlamydiaceae  MH119769
aC-262 93% Chlamydiales bacterium CRIB 32 (EU363464.1) 90% Simkaniaceae Unclassified Chlamydiales  MH119770
aC-263 97% Chlamydiales bacterium NS11 (JN606074.1) 90% Parachlamydiaceae Neochlamydia  MH119771
aC-264 Chlamydiales (Failed assembly) Chlamydiales (Failed assembly) Chlamydiales (Failed assembly)
aC-265 95% Neochlamydia sp. (LN995859.1) 93% Parachlamydiaceae Unclassified Parachlamydiaceae  MH119772
aC-268 98% Chlamydiales bacterium CRIB 32 (EU363464.1) 91% Simkaniaceae Unclassified Chlamydiales  MH119773
aC-270 Chlamydiales (Failed assembly) Chlamydiales (Failed assembly) Chlamydiales (Failed assembly)
aC-279 90% Neochlamydia hartmannellae (NR_025037.1) 90% Parachlamydiaceae Unclassified Chlamydiales  MH119774
aC-281 Chlamydiales (Failed assembly) Chlamydiales (Failed assembly) Chlamydiales (Failed assembly)
aC-282 94% Neochlamydia sp. (LN995859.1) 93% Parachlamydiaceae Unclassified Parachlamydiaceae  MH119775
aC-284 100% Chlamydia trachomatis (CP020537.1) 100% Chlamydia trachomatis Chlamydia
aC-285 96% Protochlamydia naegleriophila (LN879502.1) 96% Protochlamydia Unclassified Parachlamydiaceae  MH119776
aC-290 95% Chlamydiales bacterium CRIB 32 (EU363464.1) 92% Parachlamydiaceae Unclassified Chlamydiales  MH119777
Table 2. BLAST-n analysis and RDP classification of Chlamydiae 16 S rRNA sequences detected in ocular swabs of 
children and adults. *Uncultured bacteria were excluded from final BLAST hits by choosing the “Exclude” option 
in BLAST-n page for “Uncultured/environmental sample sequences”. #Accession numbers for submitted sequences 
to the NCBI database (https://www.ncbi.nlm.nih.gov/genbank/). §GenBank accession number was not provided 
for the cTF-092 because the BLAST query coverage was less than 90% to other Chlamydiales 16S rRNA.
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sequences had a frequency of 31.5% (17/54) among the cTF group. The remaining two positive samples showed 
sequence homology with Chlamydia caviae/Chlamydia felis and Chlamydia gallinacea and remained negative 
when tested with omcB real-time PCR. Among three assembled sequences in the cC group, two revealed highest 
similarity to both C. caviae/C. felis and one to only C. caviae (Table 2). None of the samples in the cC group exhib-
ited similarities to C. trachomatis or had positive testing results using omcB real-time PCR. Moreover, among 
the three sequences classified as Parachlamydiaceae in the cTF group, two sequences showed highest similarity 
to Parachlamydia and one to Neochlamydia. In addition, one sample (cTF051) was classified as Criblamydiaceae 
(Table 2). This is also reflected in the phylogenetic trees (Figs 2 and 3).
Altogether, C. trachomatis comprised the majority of 16S rRNA sequences compared to non-trachomatis 
Chlamydiaceae (NTC) and all CLOs among children (C. trachomatis vs. NTC and CLOs, p = 0.0005 and 
p = 0.0001, respectively) (Fig. 7a). The frequency of Chlamydiaceae sequences was significantly higher than that 
of all classified or unclassified CLOs among the children samples (p < 0.0001) (Figs 4a and 5a). No significant dif-
ferences were found between cTF and cC groups with respect to the affiliation to different CLO families (p > 0.05) 
(Fig. 7a).
Prevalence of Chlamydiae DNA in adults. Overall, 36 out of 93 (38.7%) swabs taken from adults tested 
positive for Chlamydiae DNA. Prevalence of Chlamydiae in the adult control (aC) group (20/42) was higher than 
that in adults with trachomatous trichiasis (aTT) (16/51); however, this difference was not significant (p > 0.05). 
The average CT values in the aTT and aC groups tested using Chlamydiae real-time PCR were 36.0 ± 0.45 and 
36 ± 0.8, respectively (p > 0.05) (Fig. 6a). The majority of sequences from adults were identified by BLAST 
search as being similar to the Parachlamydiaceae family (13 sequences, 46.4%), eight (28.6%) similar to the 
Chlamydiaceae and seven (25%) to the Simkaniaceae family (Table 2 and Fig. 4b). Phylogenetic analysis of the 
sequences from adults, including many lineages of yet uncultured chlamydial species, revealed three main groups 
including unclassified Chlamydiales (64.3%), Chlamydiaceae (25%), and Parachlamydiaceae (10.7%) (Fig. 5b).
The distribution of Chlamydiaceae sequences within the aTT group consisted of one sequence that showed 
highest similarity to genus Chlamydia, one to C. pecorum, and three that showed equivalent identification as 
either C. caviae or C. felis. With regard to the three controls positive for the Chlamydiaceae family, two sequences 
revealed highest similarity to C. trachomatis and also tested positive in omcB real-time PCR. The remaining sam-
ple exhibited equivalent similarity to C. caviae/C. felis (Table 2).
In general, the number of sequences classified as CLOs within the adult group was significantly higher than 
that classified as Chlamydiaceae (p = 0.0137) (Figs 4b and 5b). Nevertheless, no significant differences were found 
between aTT and aC groups with respect to the affiliation to different Chlamydiae families (p > 0.05) (Fig. 7b).
Discussion
This study provided evidence for the presence of Chlamydiaceae and CLO DNA in human ocular samples of 
patients with trachoma and healthy controls in Sudan. Overall, 36% of all samples tested positive for Chlamydiae 
DNA. Whereas the prevalence of C. trachomatis was significantly higher in children than in adults, a significantly 
higher distribution of CLO DNA was detected in adult samples compared to those from children. However, based 
on differences in the occurrence of identified CLO sequences among the patients with trachoma and healthy con-
trols in children and adults, a pathogenic role for these bacteria in trachoma is not evident.
To our knowledge, this study is the first to examine human ocular samples for the presence of all mem-
bers of the Chlamydiae. Whereas 22.9% of children’ and 8.6% of adults’ samples corresponded to Chlamydiaceae 
sequences, amplicons of 21.5% of adults’ samples and 4.2% of children samples corresponded to sequences orig-
inating from different CLOs. These results are comparable with a prior study on cats with and without (con-
trols) ocular diseases16. Specifically, C. felis, the known pathogen for feline chlamydial conjunctivitis44, was found 
among the majority of diseased eyes in animals under the age of five. The distribution of positive samples for 
non-C. felis Chlamydiales increased from 30% for cats under the age of one to 54% for cats older than 10 years 
in animals with and without ocular diseases16. Furthermore, in two separate studies, in nasopharyngeal samples 
from healthy children and adults with and without pneumonia, 11.4% of children samples and 36% of samples 
from adults tested positive for members of various families in the phylum Chlamydiae43,45. It is not clear why the 
distribution of CLOs in adults was more than five times higher than that in children. Although this difference 
might constitute a bias resulting from the small sample size in each group, this does not appear likely.
In the present study, we found a higher diversity of CLOs in adults than in children. Some of the analyzed 
sequences belong to members of the Parachlamydiaceae, which have previously been detected in other mam-
malian tissues46. Parachlamydia spp. have been found directly and indirectly in human corneal samples and dis-
posable contact lenses, respectively19,47. To our knowledge, this is the first report of Criblamydiaceae in human 
eyes. The majority of sequences obtained, however, were affiliated with various as yet uncharacterized chlamydial 
lineages. This is unexpected, because these lineages are generally to date represented only by environmental 
clone sequences, with members of such lineages not having been considered to be also associated with humans. 
Although the sequences belonging to these divergent CLOs have mainly been detected in healthy participants 
and may also originate from other sources, it is still noteworthy to find such a diversity of CLOs sequences in 
human eyes. Considering that similar profiles of CLOs were obtained among the aTT and aC groups, we cannot 
suggest any association of these bacteria with trachoma in adults. In children, the distribution of CLOs did not 
significantly differ between the cTF and cC groups.
Several studies have reported the pathogenic impacts of Parachlamydia spp. in respiratory disorders6,20,21,26 
and S. negevenesis in patients with bronchiolitis, although S. negevenesis pathogenic potential remains controver-
sial6,20,21,48–50. Notably, the possible role of some CLOs in respiratory tract infections was mainly suspected in pedi-
atric populations; similarly, in the present study, the only limited evidence suggesting a role of Parachlamydiaceae 
and Criblamydiaceae in trachoma pathogenesis was documented in children.
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In our study, no strong evidence of the pathogenic impact of CLOs on adult human eyes was obtained, which 
supports previous results by Vidgen et al. suggesting CLOs as commensals of the ocular microbiota in koala51. 
Estimated loads of CLOs in this study are comparable with the reported load of the bona fide microbiome: 100 
to 1000 colony-forming unit (CFU) per mL in human tear fluid52. These results are in line with several studies 
reporting a non-significant distribution of Parachlamydiaceae and other CLOs among diseased and healthy eyes 
of sheep, pigs, and cats16–18,53. Moreover, CLOs have been detected in different samples such as skin, nose, and 
cervicovaginal samples of healthy individuals22,38,43,45.
The high prevalence of Chlamydiae DNA in the present study is comparable with findings of human skin and nasal 
samples, which support the idea that ocular microbiota colonizes in parallel with microbiota of the upper respira-
tory system and skin22,43. This high prevalence compared to results from human respiratory or cervicovaginal samples 
can be explained through the frequent contact of the ocular surface directly or indirectly with a source of bacteria 
in the environment, infected animals, and humans. In particular, the majority of unclassified chlamydial sequences 
in this study demonstrated highest homology to previously isolated sequences from water. Additionally, members of 
Parachlamydiaceae are known to naturally infect amoeba, which they utilize as a replicative niche23,42,54–56. Moreover, 
Simkania and Criblamydia have been detected repeatedly in domestic waters14,42,54,55,57,58, which highlights the impor-
tance of water as a rich source of CLOs5 and possibly a main source of ocular infection with Chlamydiae. These results 
also emphasize the validity of environmental improvement as an essential factor of the SAFE strategy (Surgery for 
trichiasis, Antibiotics to clear ocular infection, promotion of Facial cleanliness, and Environmental improvement).
Figure 2. Phylogenetic affiliation of 16S rRNA gene sequences detected in this study. A Bayesian tree built 
from full-length chlamydial sequences is shown, to which the partial sequences generated in this study were 
added using Parsimony. Only sequences closely related to the sequences found in this study are depicted. The 
full dendrogram including all used sequences is available as Supplementary Fig. S2. Branches belonging to the 
Chlamydiaceae and CLOs are marked (light and dark purple, respectively). Sequences of cases (purple) and 
controls (dark purple) of children (cTF and cC, respectively), and cases (dark blue) and controls (cyan) of adults 
(aTT and aC, respectively), are marked.
www.nature.com/scientificreports/
8SCIEnTIFIC REPORTS |  (2018) 8:7432  | DOI:10.1038/s41598-018-23887-1
Figure 3. The maximum likelihood phylogenetic tree derived from the partial 16 S rRNA sequences detected 
in this study. Household IDs of samples are shown on left. Children cases are marked in purple (cTF), children 
controls (cC) in red, adults cases in dark blue (aTT), adults controls in cyan (aC), and the reference strains 
corresponding to species for which there was at least one best BLAST hit in black. The best BLAST hit identity 
(%) for each sample stands on the right side of the lables.
Figure 4. Abundance of 16 S rRNA gene sequences in the ocular samples taken from Al Qadarif-Sudan classified 
at the family-level in the Chlamydiae based on the closest BLAST hit. (a) Distribution of sequences obtained from 
children, assigned to members of chlamydial families. (b) Distribution of sequences obtained from adults, assigned to 
members of chlamydial families. The statistical significance is indicated as follows: **p < 0.01, and ****p < 0.0001.
www.nature.com/scientificreports/
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The profile of the Chlamydiaceae community present in ocular mucosa differed significantly between adults 
and children. Whereas C. trachomatis was only detected in two (2.1%) adult samples, 17 samples (31.5%) of 
children with TF were found to be positive for C. trachomatis. These results are consistent with previous data 
suggesting a central role for C. trachomatis in active trachoma among children1,59,60. Notably, the only two samples 
from adults that yielded positive results for C. trachomatis infection in the present study were in the aC group. 
The absence of infection with C. trachomatis in adults with trachoma can be explained through: [1] the effects 
of non-C. trachomatis bacteria and mechanical irritation on the eyes30–32,34,61,62; [2] the development of acquired 
immunity to C. trachomatis and its impact on the duration of ocular infection, which decreases significantly with 
age28,34,59,61,63; and [3] the kinetics of the disease, which can be explained by the recovery phase after repeated 
infections with C. trachomatis60. During this time, patients can be diagnosed positive for trachoma although 
Chlamydia is no longer present in the eyes60.
Classification of the Chlamydiaceae positive sequences into C. trachomatis and NTC provided an opportunity 
to investigate the prevalence of NTC bacteria. Overall, we found no association between NTC species and tra-
choma in this population. Although NTC species in the aTT group (9.8%) compared to the aC group (2.4%) were 
more frequent, this difference was not statistically significant. This is in contrast to previous studies, which found 
a high prevalence of NTC species in trachoma samples from Nepal28,29. Differences in NTC prevalence between 
present data and previous studies by Dean et al.28,29 could be due to the small sample size in all of these studies 
and regional variations.
Unfortunately, BLAST results for the majority (8/11, 72.7%) of sequences positive for NTC species could 
not differentiate between C. caviae and C. felis as the same identification score was obtained for both species. 
Moreover, the non-significant distribution of sequences positive for C. caviae/C. felis between cases compared 
to controls was unable to provide a clear indication of their role in this study. C. caviae and C. felis cause kera-
toconjunctivitis in guinea pigs and cats, respectively16,19,28,64,65. Previous studies have also reported the presence 
of C. caviae and C. felis in human eyes19,66,67. In our study, one sequence obtained in the aTT group and one in 
the cTF group demonstrated highest homology to C. pecorum and C. gallinacea, respectively. The presence of C. 
pecorum in an ocular sample from a patient with trachoma has also been previously reported29. To the best of our 
knowledge, this is the first molecular evidence of the presence of C. gallinacea DNA in humans, a species recently 
added to the Chlamydiaceae that was reported for the first time in cattle by Li et al.68 and subsequently described 
as a causative agent of avian chlamydiosis with zoonotic potential69–71.
CT values revealed important information about the bacterial load in each sample. The average CT value for 
children infected with C. trachomatis corresponds to 1.000 to 10.000 IFU per swab (Fig. 6c), whereas those for 
NTC and CLO positive samples correspond to 10 to 100 IFU per swab (Fig. 6b–d). These data support prior find-
ings that active infection (higher loads) of C. trachomatis is associated with active trachoma61,72–74. Furthermore, 
consistent with previous data, we found higher loads of bacteria in samples from children59,72,73, suggesting this 
age group as the major source of C. trachomatis infection59. Higher CT values, which are corresponding to lower 
loads of bacteria in positive samples for CLOs might be due to the persistent form of infection in these samples as 
it has been described earlier74,75. Nevertheless, high CT values may also be the consequence of an early infection, 
the presence of residual DNA from a previous infection, or inoculation of the eye with dead microorganisms28,61.
Figure 5. Abundance of 16 S rRNA gene sequences in the ocular samples taken from Al Qadarif-Sudan at the 
family-level in the Chlamydiae based on phylogenetic analysis. (a) Sequences derived from samples of children. 
(b) Sequences derived from samples of adults. The statistical significance is indicated as follows: *p < 0.05, 
**p < 0.01, and ****p < 0.0001.
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Our study also provides evidence that the presence of CLOs and C. trachomatis in human eyes was influenced 
by age. Previously, 16S rRNA gene sequencing revealed a highly diverse bacterial community in human eyes76–78. 
Moreover, age-dependent changes in the ocular microbiota have been reported in prior studies79,80. It has been 
shown that the ocular microbiome of individuals with healthy conjunctiva has a significantly different bacterial 
abundance and diversity in children aged ≤10 compared to older participants80. In addition, recent studies have 
uncovered strong evidence regarding the impacts of ocular commensal microbiota on regulating local immune 
responses and developing defense mechanisms against colonization of pathogens in the eyes52,79,81,82. The absence 
of CLOs and C. trachomatis in children and adults can thus be partially explained owing to age-dependent 
changes in the microbiota of eyes and its impacts on the development of different local immune responses. This 
may in turn influence the presence of Chlamydiae and multiplicity of infection. For example, a study on the cer-
vical microbiota of women infected with C. trachomatis and healthy controls have shown a different diversity of 
microbiota in those with asymptomatic infection of C. trachomatis83. Additionally, the abundance of bacterial taxa 
was different in the cervical microbiota of women infected with C. trachomatis compared to that in healthy con-
trols83. Vidgen et al. have also demonstrated a correlation between urogenital microbiota of koalas and infection 
with C. pecorum51. Furthermore, previous results have shown that co-infection of C. trachomatis serovar E and 
another intracellular pathogen, Toxoplasma gondii, can lead to a stress-induced persistent growth of C. trachoma-
tis in the host cells owing to better ability of T. gondii in scavenging nutrients inside the cells84. The suggestion of 
Figure 6. Average real-time PCR threshold cycle (CT) values for amplification of the Chlamydiae 16 S rRNA 
gene. (a) Recorded CT values for positive samples among children and adults. The children case group 
showed significantly lower CT values compared to the children control group and adults case and control 
groups. (b) Recorded CT values for 16 S rRNA sequences classified as families in the phylum Chlamydiae, 
C. trachomatis (CT), and non-trachomatis Chlamydiaceae (NTC). CT values were significantly lower for the 
Chlamydiaceae family compared to Parachlamydiaceae, Simkaniaceae, and Criblamydiaceae families. CT 
values for positive samples for C. trachomatis were recorded as significantly lower than those for NTC positive 
samples. (c) Recorded CT values for 16 S rRNA sequences classified as families in the phylum Chlamydiae, 
CT, and NTC among children. (d) Recorded CT values for 16 S rRNA sequences classified as families in the 
phylum Chlamydiae, CT, and NTC among adults. The statistical significance is indicated as follows: *p < 0.05, 
**p < 0.01, ***p < 0.001, and ****p < 0.0001.
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CLOs as comprising part of the commensal microbiota of the eye thus raises the question of whether the presence 
of CLOs can influence successful infection of C. trachomatis in human eyes.
This study has several limitations. As the sample size was relatively small, the use of a larger sample size within 
this study might have minimized the bias in biodiversity of detected CLOs in each group and provided a better 
understanding of the possible associations of CLOs and NTC species with eye health or disease. In addition, the 
length of the amplicons used for sequencing was not sufficient to resolve the species (i.e. C. felis/C. caviae) or 
genus level in every case, due to the sequence identity or low representation of many chlamydial lineages in public 
databases, respectively.
In summary, C. trachomatis is associated with active trachoma in Sudanese children. We presented evidence 
demonstrating an age-dependent distribution of divergent groups of CLOs in human eyes. However, the biology 
of the CLOs identified in this study remains unknown. Our findings do not support a significant association 
between the presence of CLOs and NTC species and active trachoma in children or TT in adults. Comparative 
studies with a larger sample size on the prevalence of CLOs in human eyes from different geographic regions may 
provide insight into the possible role of these microorganisms in pathogenicity and/or protection. Further stud-
ies are needed to understand the impacts of ocular microbiota and local immune responses on the presence of 
C. trachomatis and CLOs in the eyes.
Material and Methods
Ethical approval. The study was conducted in accordance with the Declaration of Helsinki. The National 
Ethics Authorities in Sudan (Sudanese National Research Ethics Review Committee (NRERC) (No. 174-8-12)) 
and the ethical committee of the Medical University of Vienna approved the study and all the included proce-
dures. Written informed consent was obtained from all adult individuals at the time of sample collection. For 
those participants aged <18 years that wished to take part in the study, consent was obtained from a parent/
guardian. All samples were anonymized.
Figure 7. Distribution of 16 S rRNA gene sequences assigned to families in the phylum Chlamydiae, C. 
trachomatis (CT), and non-trachomatis Chlamydiaceae (NTC) among (a) children and (b) adults. Prevalence of 
classified sequences as CT in the children case group was significantly higher than that in the children control 
group. The statistical significance is indicated as follows: *p < 0.05, ***p < 0.001, and ****p < 0.0001.
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Trachoma grading. Clinical phenotypes were assessed in the field by an experienced ophthalmologist 
trained in trachoma grading using the World Health Organization simplified grading system85. Individuals pre-
senting with follicular trachoma were classified as TF, individuals with pronounced papillary hypertrophy and 
inflammatory thickening of tarsal conjunctiva were classified as “Trachomatous Inflammation − Intense (TI)” 
and individuals with tarsal conjunctival scarring as “Trachomatous scarring (TS)”. Individuals with inturned 
eyelashes were graded as TT. Individuals with no clinical signs of follicles, papillary hypertrophy, or conjunctival 
scarring were classed as healthy controls. Cases and controls were matched by age and gender.
Study population and sampling. Participants for this study were recruited in trachoma endemic areas 
in Sudan86. For adults with TT, sample collection took place in a Field Surgery Clinic in the Al Qadarif region 
(Fig. 1). A total of 51 aTT scheduled for trichiasis surgery and 42 matched aC without history and present signs 
of trachoma were enrolled. In addition, 54 cTF and 42 cC subjects aged 1 to 9 years were recruited at two Quran 
Schools in the Al Qadarif region. Conjunctival samples were taken from the upper tarsal conjunctiva from both 
eyes using polyester flocked swabs (UTM-RT collection kits, Copan USA, Murrieta, CA, USA) using standard 
methodology87,88. The sampling ophthalmologist wore gloves that were changed after each individual. Swabs were 
stored in universal transport medium and frozen immediately in liquid nitrogen cryogenic shipping containers. 
In Austria, samples were subsequently stored at −80 °C.
DNA preparation. Genomic DNA was extracted from the conjunctival swab samples taken from left eyes. As a 
nucleic acid extraction negative control, one empty swab was included during each DNA extraction run. Each swab was 
vigorously vortexed for 5 min inside the universal transport medium, then the entire transport medium was transferred 
to a new tube. Cells in the swab transport medium were pelleted by centrifugation at 17,000 × g for 30 min. DNA was 
extracted from the resuspended pellet in ATL buffer of the QIAamp DNA Investigator Kit (QIAGEN GmbH, Hilden, 
Germany), according to manufacturer instruction, and DNA was stored at −20 °C until further use.
Broad-range Chlamydiae real-time PCR and sequencing. A Chlamydiae-specific real-time PCR was 
performed on a final reaction volume of 20 µL targeting a fragment of approximately 207 to 215 bp of the 16S 
rRNA gene as described by Lienard et al.45. Cycling conditions were 5 min at 95 °C, followed by 50 repetitions of 
3-step cycles of 15 s at 95 °C, 20 s at 67 °C, and 15 s at 72 °C, all carried out in a PikoReal real-time PCR System 
(Thermo Fisher Scientific). All samples were tested in duplicate. After optimization of the PCR, a CT value of 
≤37 has been suggested as a reliable cutoff to provide reproducible results and samples with this CT value were 
considered as positive samples. In each run, 2 wells were dedicated to negative controls (distilled water) and 2 
wells were used as nucleic acid extraction negative controls. A standard curve was generated for each real-time 
PCR run using decimal serial dilutions of extracted genomic DNA from 1 × 106 to 1 × 101 IFUs of C. trachomatis 
(Supplementary Fig. S1).
Purification of amplicons for positive samples was performed using the QIAquick PCR Purification Kit 
(QIAGEN GmbH) according to the manufacturer’s protocol. Sanger sequencing of purified PCR products was 
performed by Eurofins Genomics AT (Vienna, Austria). Inner primers (panFseq and panRseq) resulted in an 
approximately 200 bp amplicon as explained previously by Lienard et al.45.
Specific TaqMan real-time PCR for the omcB gene of C. trachomatis. To assess C. trachomatis preva-
lence in particular, a specific real-time PCR was carried out on all samples to target the omcB gene of C. trachomatis. 
The reaction was performed in a final volume of 20 µL using iTaq Supermix (BioRad, Reinach, Switzerland), 0.3 µM 
concentration of each primer, 0.1 µM concentration of probe, and 5 µL sample DNA89. The program was set at 95 °C 
for 5 min, followed by 45 cycles of 15 s at 95 °C and 30 s at 60 °C, all carried out in a PikoReal real-time PCR System. 
All samples were tested in duplicate. Samples with a CT value of ≤37 were considered as positive. Distilled water 
(a negative control) and C. trachomatis DNA (a positive control) were included in each experiment.
Data analysis. The obtained partial forward and reverse sequences of 16S rRNA gene were trimmed, aligned 
and assembled in the Geneious R10.2.2 software package. Of the resulting 55 sequences, 50 (90.9%) were of high 
quality with average phred quality scores above 30 and 5 (9.1%) of the sequences had average phred quality scores 
above 23 (cTF-025, aC-259, aC-261, aC-268 and aC-285). All consensus sequences were checked for the presence 
of chimera with DECIPHER90 and compared with sequences available in the GenBank database of the National 
Center for Biotechnology Information via the BLAST server (https://www.ncbi.nlm.nih.gov/blast/). 16S rRNA 
gene identification cut-offs of 97, 95, and 90% were applied for the achieved sequences to approximately classify 
members of the phylum Chlamydiae to the species, genus, and family levels, respectively91. In addition, the 16S 
rRNA sequences were classified with the Naïve Bayesian classifier of RDP using a 70% confidence interval92. 
Obtained nucleotide sequences have been submitted to the NCBI database (https://www.ncbi.nlm.nih.gov/gen-
bank/) under accession numbers (MH119764-99).
Based on the results from sequencing of 16S rRNA gene sequences and C. trachomatis omcB real-time PCR, 
samples assigned to the Chlamydiaceae were divided into two groups: C. trachomatis and NTC.
Phylogenetic analysis. Phylogenetic analyses were carried out with two datasets. First, a dataset contained 
full-length 16S rRNA gene sequences of Chlamydiae, which were downloaded from GenBank and aligned to 
the SILVA SSU Ref database containing preconfigured high-quality full-length sequences in ARB93,94. Bayesian 
inference analysis of full-length 16S rRNA gene sequences was carried out with MrBayes 3.2.6 using standard 
settings via the CIPRES Science Gateway95,96. The partial 16S rRNA gene sequences obtained in this study were 
added subsequently to the Bayesian tree using the Quick-Add Parsimony option in ARB93. The phylogenetic tree 
was visualized with iTOL and FigTree97,98 (Fig. 2).
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Second, all obtained consensus sequences as well as the 16S rRNA gene sequences of C. trachomatis A/
Har-13T (A_E17344.1), C. caviae strain: Gp/Ic (=ATCC VR813) (D85708.1), N. hartmannellae strain A1Hsp 
(NR_025037.1), Criblamydia sequanensis strain CRIB-18 (NR_115696.1), S. negevensis strain Z (NR_029194.1), 
and P. acanthamoebae strain CRIB43 (FJ532291.1) were used. Sequences were aligned using MAFFT v7.30999. 
Jalview v2.10.1 was used to trim the alignment and to look for reverse complemented sequences100. Maximum 
likelihood-based phylogenetic analyses were performed using FastTree 2.1 software (with parameters “-nt -gtr 
-spr 4 -mlacc 2 -slownni”)101. The phylogenetic representation was rerooted at the midpoint using Archaeopterix 
v0.9920102 and displayed with FigTree v1.4.298 (Fig. 3).
Statistics. Variables were compared by t test. A p-value < 0.05 was taken as statistically significant. Data anal-
ysis was performed using GraphPad Prism 6.0 (GraphPad Inc., La Jolla, CA, USA) software.
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